Sara Costa Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sara Costa Silva has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Domingos Leite de Castro
Neuroengineering and Computational Neuroscience Lab, i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto
2 shared publications - Isabel Cardoso
I3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
2 shared publications - Miguel Aroso
University of Porto Institute for Research and Innovation in Health Sciences, Rua Alfredo Allen, 208, Porto, 4200-135, Portugal
2 shared publications - Mobina Alemi
Instituto de Investigação e Inovação em Saúde—Pain Neurobiology Group, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal
2 shared publications - Paulo Aguiar
I3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
2 shared publications - Brígida Mónica Faria
ESTSP/IPP - Escola Superior de Tecnologia da Saúde do Porto, Instituto Politécnico do Porto, Gaia, Portugal
1 shared publication
Latest Publications
- Open Access
- 11 May 2026
- Published by IOP Publishing in Journal of Neural Engineering
- Vol. 23 (3)
Electrically evoked calcium waves and membrane oscillations reveal astrocytic excitability in the neurostimulation range
Objective. Electrical brain stimulation (EBS) has emerged as a valuable therapeutic tool for neurological and psychiatric disorders, but its underlying mechanisms remain poorly understood. Namely, the direct impact of electrical stimulation on astrocytic activity has been overlooked, as neurons have been historically the primary focus of EBS research. This study aimed to improve the characterization of astrocytes’ response to extracellular electrical stimulation. Approach. Primary astrocyte cultures (rat) were cultured on microelectrode arrays to assess direct astrocytic responses, eliminating neuronal contributions. Astrocytic responsiveness to electrical stimulation was assessed by simultaneously monitoring electrophysiological activity and intracellular calcium dynamics, the hallmark of astrocytic signalling. This in vitro system provided ideal control conditions for high spatiotemporal analysis of astrocytic dynamics. Main results. Electrical stimulation elicited both membrane voltage oscillations and radial calcium waves in astrocytes. Calcium responses were significantly larger than spontaneous activity and displayed a stimulus-dependent refractory period. Responses were partially dependent on extracellular calcium and modulated by N-type voltage-gated calcium channels, ATP-mediated signalling via P2X receptors, and gap junction communication. Calcium waves were abolished upon substitution with nominally calcium-free HBSS, while electrophysiological responses persisted, indicating parallel and partially independent signalling mechanisms. Importantly, astrocytes exhibited reliable activation exactly in the same stimulation amplitudes as those used for neuronal activation. Significance. Altogether, this study demonstrates that astrocytes respond to electrical stimulation within physiologically relevant ranges, highlighting their potential as key contributors, and direct therapeutic targets (astrocyte-optimized electrical stimulation), in neurostimulation. These results urge a reconsideration of astrocytic roles in neurostimulation protocols and may guide the design of more effective brain stimulation therapies.
- 11 May 2026
- Published by IOP Publishing in Journal of Neural Engineering
- Vol. 23 (3)
Open AccessElectrically evoked calcium waves and membrane oscillations reveal astrocytic excitability in the neurostimulation range
Objective. Electrical brain stimulation (EBS) has emerged as a valuable therapeutic tool for neurological and psychiatric disorders, but its underlying mechanisms remain poorly understood. Namely, the direct impact of electrical stimulation on astrocytic activity has been overlooked, as neurons have been historically the primary focus of EBS research. This study aimed to improve the characterization of astrocytes’ response to extracellular electrical stimulation. Approach. Primary astrocyte cultures (rat) were cultured on microelectrode arrays to assess direct astrocytic responses, eliminating neuronal contributions. Astrocytic responsiveness to electrical stimulation was assessed by simultaneously monitoring electrophysiological activity and intracellular calcium dynamics, the hallmark of astrocytic signalling. This in vitro system provided ideal control conditions for high spatiotemporal analysis of astrocytic dynamics. Main results. Electrical stimulation elicited both membrane voltage oscillations and radial calcium waves in astrocytes. Calcium responses were significantly larger than spontaneous activity and displayed a stimulus-dependent refractory period. Responses were partially dependent on extracellular calcium and modulated by N-type voltage-gated calcium channels, ATP-mediated signalling via P2X receptors, and gap junction communication. Calcium waves were abolished upon substitution with nominally calcium-free HBSS, while electrophysiological responses persisted, indicating parallel and partially independent signalling mechanisms. Importantly, astrocytes exhibited reliable activation exactly in the same stimulation amplitudes as those used for neuronal activation. Significance. Altogether, this study demonstrates that astrocytes respond to electrical stimulation within physiologically relevant ranges, highlighting their potential as key contributors, and direct therapeutic targets (astrocyte-optimized electrical stimulation), in neurostimulation. These results urge a reconsideration of astrocytic roles in neurostimulation protocols and may guide the design of more effective brain stimulation therapies.
- Open Access
Bringing astrocytes into the spotlight of electrical brain stimulation
Astrocytes, primarily viewed only as supportive units, are now emerging as active players in the information processing of the brain. Accumulated evidence supports that the bidirectional communication between astrocytes and neurons maintains complex animal behaviours such as memory formation and decision-making. The lack of characterisation of astrocytic electrophysiology is, in our opinion, associated with the early idea of a passive electrical nature of astrocytes, in opposition to the electrically active neurons. A better understanding of the effect of electrical stimulation on astrocytes’ physiology and activity will greatly strengthen the current knowledge in neural biology. Here, we assessed if astrocytes may have a role in therapies based on electrical brain stimulation by being able to respond to the same electrical stimulus used to modulate neuronal activity. To do so, we took advantage of microelectrode arrays (MEAs) capability to simultaneously record and deliver extracellular electrical signals. Additionally, we synchronized the recording of electrophysiological data with the recording of calcium activity, a hallmark of astrocytic activity. Here, we show that astrocytes respond to electrical stimulation with the generation of strong membrane voltage oscillations and simultaneous production of calcium waves, demonstrating, unequivocally, that astrocytes respond to electrical stimulation in the same range as neurons do. Importantly, these responses are dependent on the stimuli amplitude. Furthermore, membrane voltage oscillations are significantly reduced in the absence of extracellular calcium, but not abolished, while calcium activity is not detected.
Open AccessBringing astrocytes into the spotlight of electrical brain stimulation
Astrocytes, primarily viewed only as supportive units, are now emerging as active players in the information processing of the brain. Accumulated evidence supports that the bidirectional communication between astrocytes and neurons maintains complex animal behaviours such as memory formation and decision-making. The lack of characterisation of astrocytic electrophysiology is, in our opinion, associated with the early idea of a passive electrical nature of astrocytes, in opposition to the electrically active neurons. A better understanding of the effect of electrical stimulation on astrocytes’ physiology and activity will greatly strengthen the current knowledge in neural biology. Here, we assessed if astrocytes may have a role in therapies based on electrical brain stimulation by being able to respond to the same electrical stimulus used to modulate neuronal activity. To do so, we took advantage of microelectrode arrays (MEAs) capability to simultaneously record and deliver extracellular electrical signals. Additionally, we synchronized the recording of electrophysiological data with the recording of calcium activity, a hallmark of astrocytic activity. Here, we show that astrocytes respond to electrical stimulation with the generation of strong membrane voltage oscillations and simultaneous production of calcium waves, demonstrating, unequivocally, that astrocytes respond to electrical stimulation in the same range as neurons do. Importantly, these responses are dependent on the stimuli amplitude. Furthermore, membrane voltage oscillations are significantly reduced in the absence of extracellular calcium, but not abolished, while calcium activity is not detected.
- 24 March 2018
- Published by Springer Nature
- p. 19-28
Protein Attributes-Based Predictive Tool in a Down Syndrome Mouse Model: A Machine Learning Approach
- 24 March 2018
- Published by Springer Nature
- p. 19-28
Protein Attributes-Based Predictive Tool in a Down Syndrome Mouse Model: A Machine Learning Approach
- 1 June 2017
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 23 (7) , 605-619
Transthyretin stability is critical in assisting beta amyloid clearance– Relevance of transthyretin stabilization in Alzheimer's disease
Summary: Background: The absence of transthyretin (TTR) in AD mice decreases brain Aβ clearance and reduces the low‐density lipoprotein receptor‐related protein 1 (LRP1). It is possible that neuroprotection by TTR is dependent on its tetramer structural stability, as studies using TTR mutants showed that unstable L55P TTR has low affinity for Aβ, and TTR tetrameric stabilizers such as iododiflunisal ameliorate AD features in vivo.Methods: We firstly investigated TTR folding status in human plasma measuring the resistance to urea denaturation. The importance of TTR stability on Aβ internalization was studied in human cerebral microvascular endothelial (hCMEC/D3) and hepatoma cells (HepG2), by flow cytometry. To investigate the fate of Aβ at the blood–brain barrier, Aβ efflux from hCMEC/D3 cells seeded on transwells was measured using ELISA. Further, to assess Aβ colocalization with lysosomes, Lysotracker was used. Moreover, levels of LRP1 were assessed in the liver and plasma of mice with different TTR backgrounds or treated with iododiflunisal.Results: We showed that TTR stability is decreased in AD and that WT TTR and drug‐stabilized L55P TTR are able to increase uptake of Aβ. Furthermore, measurement of Aβ efflux showed that stable or stabilized TTR increased Aβ efflux from the basolateral to the apical side. Moreover, HepG2 cells incubated with Aβ in the presence of WT TTR, but not L55P TTR, showed an increased number of lysosomes. Further, in the presence of WT TTR, Aβ peptide colocalized with lysosomes, indicating that only stable TTR assists Aβ internalization, leading to its degradation. Finally, we demonstrated that only stable TTR can increase LRP1 levels.Conclusion: TTR stabilization exerts a positive effect on Aβ clearance and LRP1 levels, suggesting that TTR protective role in AD is dependent on its stability. These results provide relevant information for the design of TTR‐based therapeutic strategies for AD.
- 1 June 2017
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 23 (7) , 605-619
Transthyretin stability is critical in assisting beta amyloid clearance– Relevance of transthyretin stabilization in Alzheimer's disease
Summary: Background: The absence of transthyretin (TTR) in AD mice decreases brain Aβ clearance and reduces the low‐density lipoprotein receptor‐related protein 1 (LRP1). It is possible that neuroprotection by TTR is dependent on its tetramer structural stability, as studies using TTR mutants showed that unstable L55P TTR has low affinity for Aβ, and TTR tetrameric stabilizers such as iododiflunisal ameliorate AD features in vivo.Methods: We firstly investigated TTR folding status in human plasma measuring the resistance to urea denaturation. The importance of TTR stability on Aβ internalization was studied in human cerebral microvascular endothelial (hCMEC/D3) and hepatoma cells (HepG2), by flow cytometry. To investigate the fate of Aβ at the blood–brain barrier, Aβ efflux from hCMEC/D3 cells seeded on transwells was measured using ELISA. Further, to assess Aβ colocalization with lysosomes, Lysotracker was used. Moreover, levels of LRP1 were assessed in the liver and plasma of mice with different TTR backgrounds or treated with iododiflunisal.Results: We showed that TTR stability is decreased in AD and that WT TTR and drug‐stabilized L55P TTR are able to increase uptake of Aβ. Furthermore, measurement of Aβ efflux showed that stable or stabilized TTR increased Aβ efflux from the basolateral to the apical side. Moreover, HepG2 cells incubated with Aβ in the presence of WT TTR, but not L55P TTR, showed an increased number of lysosomes. Further, in the presence of WT TTR, Aβ peptide colocalized with lysosomes, indicating that only stable TTR assists Aβ internalization, leading to its degradation. Finally, we demonstrated that only stable TTR can increase LRP1 levels.Conclusion: TTR stabilization exerts a positive effect on Aβ clearance and LRP1 levels, suggesting that TTR protective role in AD is dependent on its stability. These results provide relevant information for the design of TTR‐based therapeutic strategies for AD.
- Open Access
- 1 January 2016
- Published by Springer Nature in Molecular Medicine
- Vol. 22 (1) , 597-607
Resveratrol Administration Increases Transthyretin Protein Levels, Ameliorating AD Features: The Importance of Transthyretin Tetrameric Stability
Previous in vivo work showed that resveratrol has beneficial effects in the AD pathology, resulting in increased expression of transthyretin (TTR). TTR binds Aβ peptide avoiding its aggregation and toxicity, and is reduced in the CSF and plasma, in AD. Further, resveratrol binds TTR, stabilizing the native TTR tetrameric structure. To further explore the mechanism of neuroprotection conferred by TTR in AD, resveratrol was administrated, in the diet, to 5-8 months old AD transgenic female mice carrying just one copy of the mouse TTR gene, for two months. Effects in brain Aβ burden were evaluated by immunohistochemistry, and in total brain Aβ levels by ELISA, showing a striking decrease in both parameters in treated animals. In addition, total brain LRP1 protein levels were increased in treated animals, although its gene expression was unaltered. To further understand the mechanism(s) underlying such improvement in AD features, we measured TTR plasma levels showing that TTR increased in resveratrol-treated mice, whereas liver TTR gene transcription was not altered. These results strengthen the stability hypothesis, which postulates that TTR is unstable in AD leading to accelerated clearance and lower levels. Therefore, resveratrol which stabilizes the TTR tetramer results in TTR normalized clearance, thus increasing the protein plasma levels. In turn, stabilized TTR binds more strongly to Aβ peptide, avoiding its aggregation. Our results represent a step forward to the understanding of the mechanism underlying TTR protection in AD and highlight the possibility of using TTR stabilization as a therapeutic target in AD.
- 1 January 2016
- Published by Springer Nature in Molecular Medicine
- Vol. 22 (1) , 597-607
Open AccessResveratrol Administration Increases Transthyretin Protein Levels, Ameliorating AD Features: The Importance of Transthyretin Tetrameric Stability
Previous in vivo work showed that resveratrol has beneficial effects in the AD pathology, resulting in increased expression of transthyretin (TTR). TTR binds Aβ peptide avoiding its aggregation and toxicity, and is reduced in the CSF and plasma, in AD. Further, resveratrol binds TTR, stabilizing the native TTR tetrameric structure. To further explore the mechanism of neuroprotection conferred by TTR in AD, resveratrol was administrated, in the diet, to 5-8 months old AD transgenic female mice carrying just one copy of the mouse TTR gene, for two months. Effects in brain Aβ burden were evaluated by immunohistochemistry, and in total brain Aβ levels by ELISA, showing a striking decrease in both parameters in treated animals. In addition, total brain LRP1 protein levels were increased in treated animals, although its gene expression was unaltered. To further understand the mechanism(s) underlying such improvement in AD features, we measured TTR plasma levels showing that TTR increased in resveratrol-treated mice, whereas liver TTR gene transcription was not altered. These results strengthen the stability hypothesis, which postulates that TTR is unstable in AD leading to accelerated clearance and lower levels. Therefore, resveratrol which stabilizes the TTR tetramer results in TTR normalized clearance, thus increasing the protein plasma levels. In turn, stabilized TTR binds more strongly to Aβ peptide, avoiding its aggregation. Our results represent a step forward to the understanding of the mechanism underlying TTR protection in AD and highlight the possibility of using TTR stabilization as a therapeutic target in AD.